Hemagglutination inhibition antibody titer D0,D21,D35 [clinicaltrials_resource:872c743725498f491b3a3b54d4546162]

Hemagglutination inhibition antibody titer D0,D21,D35 [clinicaltrials_resource:872c743725498f491b3a3b54d4546162]

440 participants (110 elders, 110 adults, 110 adolescents and 110 children) to receive split-virion, non-adjuvanted H1N1 vaccine of 30 μg on day 0 and 21.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:872c743725498f491b3a3b54d4546162
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older [clinicaltrials:NCT00975572]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Hemagglutination inhibition antibody titer D0,D21,D35 [clinicaltrials_resource:872c743725498f491b3a3b54d4546162]

440 participants (110 elders, 110 adults, 110 adolescents and 110 children) to receive split-virion, non-adjuvanted H1N1 vaccine of 30 μg on day 0 and 21.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:872c743725498f491b3a3b54d4546162
Bio2RDF identifier
872c743725498f491b3a3b54d4546162
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:872c743725498f491b3a3b54d4546162
measure [clinicaltrials_vocabulary:measure]
Hemagglutination inhibition antibody titer
time frame [clinicaltrials_vocabulary:time-frame]
description
440 participants (110 elders, ...... cine of 30 μg on day 0 and 21.
identifier
clinicaltrials_resource:872c743725498f491b3a3b54d4546162
title
Hemagglutination inhibition antibody titer D0,D21,D35
@en
inDataset
type
label
Hemagglutination inhibition an ...... c743725498f491b3a3b54d4546162]
@en